189 related articles for article (PubMed ID: 31876783)
1. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency.
Maggiore R; Grossi A; Fioredda F; Palmisani E; Terranova P; Cappelli E; Lanza T; Pierri F; Guardo D; Calvillo M; Micalizzi C; Beccaria A; Coccia MC; Arrigo S; Dufour C; Ceccherini I; Miano M
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e768-e771. PubMed ID: 31876783
[TBL] [Abstract][Full Text] [Related]
2. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.
Kiykim A; Ogulur I; Dursun E; Charbonnier LM; Nain E; Cekic S; Dogruel D; Karaca NE; Cogurlu MT; Bilir OA; Cansever M; Kapakli H; Baser D; Kasap N; Kutlug S; Altintas DU; Al-Shaibi A; Agrebi N; Kara M; Guven A; Somer A; Aydogmus C; Ayaz NA; Metin A; Aydogan M; Uncuoglu A; Patiroglu T; Yildiran A; Guner SN; Keles S; Reisli I; Aksu G; Kutukculer N; Kilic SS; Yilmaz M; Karakoc-Aydiner E; Lo B; Ozen A; Chatila TA; Baris S
J Allergy Clin Immunol Pract; 2019; 7(8):2790-2800.e15. PubMed ID: 31238161
[TBL] [Abstract][Full Text] [Related]
3. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
Lo B; Zhang K; Lu W; Zheng L; Zhang Q; Kanellopoulou C; Zhang Y; Liu Z; Fritz JM; Marsh R; Husami A; Kissell D; Nortman S; Chaturvedi V; Haines H; Young LR; Mo J; Filipovich AH; Bleesing JJ; Mustillo P; Stephens M; Rueda CM; Chougnet CA; Hoebe K; McElwee J; Hughes JD; Karakoc-Aydiner E; Matthews HF; Price S; Su HC; Rao VK; Lenardo MJ; Jordan MB
Science; 2015 Jul; 349(6246):436-40. PubMed ID: 26206937
[TBL] [Abstract][Full Text] [Related]
4. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.
Gámez-Díaz L; August D; Stepensky P; Revel-Vilk S; Seidel MG; Noriko M; Morio T; Worth AJJ; Blessing J; Van de Veerdonk F; Feuchtinger T; Kanariou M; Schmitt-Graeff A; Jung S; Seneviratne S; Burns S; Belohradsky BH; Rezaei N; Bakhtiar S; Speckmann C; Jordan M; Grimbacher B
J Allergy Clin Immunol; 2016 Jan; 137(1):223-230. PubMed ID: 26768763
[TBL] [Abstract][Full Text] [Related]
5. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
[TBL] [Abstract][Full Text] [Related]
6. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.
Burnett DL; Parish IA; Masle-Farquhar E; Brink R; Goodnow CC
Immunol Cell Biol; 2017 Oct; 95(9):775-788. PubMed ID: 28611475
[TBL] [Abstract][Full Text] [Related]
7. Leishmaniasis and Autoimmunity in Patient with LPS-Responsive Beige-Like Anchor Protein (LRBA) Deficiency.
Salami F; Shirkani A; Shahrooei M; Azizi G; Yazdani R; Abolhassani H; Aghamohammadi A
Endocr Metab Immune Disord Drug Targets; 2020; 20(3):479-484. PubMed ID: 31389321
[TBL] [Abstract][Full Text] [Related]
8. Arthritis in children with LRBA deficiency - case report and literature review.
Semo Oz R; S Tesher M
Pediatr Rheumatol Online J; 2019 Dec; 17(1):82. PubMed ID: 31847838
[TBL] [Abstract][Full Text] [Related]
9. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.
Bratanič N; Kovač J; Pohar K; Trebušak Podkrajšek K; Ihan A; Battelino T; Avbelj Stefanija M
Orphanet J Rare Dis; 2017 Jul; 12(1):131. PubMed ID: 28720148
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.
Taghizade N; Babayeva R; Kara A; Karakus IS; Catak MC; Bulutoglu A; Haskologlu ZS; Akay Haci I; Tunakan Dalgic C; Karabiber E; Bilgic Eltan S; Yorgun Altunbas M; Sefer AP; Sezer A; Kokcu Karadag SI; Arik E; Karali Z; Ozhan Kont A; Tuzer C; Karaman S; Mersin SS; Kasap N; Celik E; Kocacik Uygun DF; Aydemir S; Kiykim A; Aydogmus C; Ozek Yucel E; Celmeli F; Karatay E; Bozkurtlar E; Demir S; Metin A; Karaca NE; Kutukculer N; Aksu G; Guner SN; Keles S; Reisli I; Kendir Demirkol Y; Arikoglu T; Gulez N; Genel F; Kilic SS; Aytekin C; Keskin O; Yildiran A; Ozcan D; Altintas DU; Ardeniz FO; Dogu EF; Ikinciogullari KA; Karakoc-Aydiner E; Ozen A; Baris S
J Allergy Clin Immunol; 2023 Dec; 152(6):1634-1645. PubMed ID: 37595759
[TBL] [Abstract][Full Text] [Related]
11. Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients.
Shamriz O; Shadur B; NaserEddin A; Zaidman I; Simanovsky N; Elpeleg O; Kerem E; Reiter J; Stepensky P
Eur J Pediatr; 2018 Aug; 177(8):1163-1172. PubMed ID: 29777306
[TBL] [Abstract][Full Text] [Related]
12. Patients with "ALPS-like phenotype" diagnosed with immune dysregulation due to LRBA deficiency.
Fernández KS; Antony R; Kumar A
Pediatr Blood Cancer; 2019 Mar; 66(3):e27558. PubMed ID: 30479033
[No Abstract] [Full Text] [Related]
13. Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation.
Alroqi FJ; Charbonnier LM; Baris S; Kiykim A; Chou J; Platt CD; Algassim A; Keles S; Al Saud BK; Alkuraya FS; Jordan M; Geha RS; Chatila TA
J Allergy Clin Immunol; 2018 Mar; 141(3):1050-1059.e10. PubMed ID: 28601686
[TBL] [Abstract][Full Text] [Related]
14. LRBA deficiency: a rare cause of type 1 diabetes, colitis, and severe immunodeficiency.
Kardelen AD; Kara M; Güller D; Ozturan EK; Abalı ZY; Ceylaner S; Kıykım A; Cantez S; Torun SH; Poyrazoglu S; Bas F; Darendelıler F
Hormones (Athens); 2021 Jun; 20(2):389-394. PubMed ID: 33155142
[TBL] [Abstract][Full Text] [Related]
15. Identifying Novel Mutations in Iranian Patients with LPS-responsive Beige-like Anchor Protein (LRBA) Deficiency.
Ghaini M; Arzanian MT; Shamsian BS; Sadr S; Rohani P; Keramatipour M; Mesdaghi M; Eskandarzadeh S; Lo B; Jamee M; Chavoshzadeh Z
Immunol Invest; 2021 May; 50(4):399-405. PubMed ID: 32476511
[TBL] [Abstract][Full Text] [Related]
16. Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review.
Habibi S; Zaki-Dizaji M; Rafiemanesh H; Lo B; Jamee M; Gámez-Díaz L; Salami F; Kamali AN; Mohammadi H; Abolhassani H; Yazdani R; Aghamohammadi A; Anaya JM; Azizi G
J Allergy Clin Immunol Pract; 2019; 7(7):2379-2386.e5. PubMed ID: 30995531
[TBL] [Abstract][Full Text] [Related]
17. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency.
Catak MC; Akcam B; Bilgic Eltan S; Babayeva R; Karakus IS; Akgun G; Baser D; Bulutoglu A; Bayram F; Kasap N; Kiykim A; Hancioglu G; Kokcu Karadag SI; Kendir Demirkol Y; Ozen S; Cekic S; Ozcan D; Edeer Karaca N; Sasihuseyinoglu AS; Cansever M; Ozek Yucel E; Tamay Z; Altintas DU; Aydogmus C; Celmeli F; Cokugras H; Gulez N; Genel F; Metin A; Guner SN; Kutukculer N; Keles S; Reisli I; Kilic SS; Yildiran A; Karakoc-Aydiner E; Lo B; Ozen A; Baris S
Allergy; 2022 Oct; 77(10):3108-3123. PubMed ID: 35491430
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency.
Boz V; Valencic E; Girardelli M; Pin A; Gàmez-Diaz L; Tommasini A; Lega S; Bramuzzo M
Front Immunol; 2021; 12():619246. PubMed ID: 33717114
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Expression of LRBA and CTLA-4 Proteins in Common Variable Immunodeficiency Patients.
Salami F; Fekrvand S; Yazdani R; Shahkarami S; Azizi G; Bagheri Y; Delavari S; Shariati S; Mahdaviani SA; Nabavi M; Shirkani A; Abolhassani H; Samadi M; Aghamohammadi A
Immunol Invest; 2022 Feb; 51(2):381-394. PubMed ID: 33191838
[TBL] [Abstract][Full Text] [Related]
20. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy.
Ureshino H; Koarada S; Kamachi K; Yoshimura M; Yokoo M; Kubota Y; Ando T; Ichinohe T; Morio T; Kimura S
Int J Hematol; 2020 Jun; 111(6):897-902. PubMed ID: 31993940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]